• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 1
  • Tagged with
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Síntese, caracterização e atividade antimicrobiana de compostos heterocíclicos da classe 2,3-diidro-1,3,4-oxadiazol derivados de N-acilhidrazonas / Synthesis, characterization and antimicrobial activity of heterocyclic compounds of the class 2,3-dihydro-1,3,4-oxadiazole derivatives of N-acylhydrazone

Oliveira, Cledualdo Soares de 18 January 2013 (has links)
Made available in DSpace on 2015-05-14T13:21:26Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 8587505 bytes, checksum: 3dc99b05c6b4e46c71e2ec550261f7cf (MD5) Previous issue date: 2013-01-18 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Among the heterocyclic compounds, 1,3,4-oxadiazole represents an important unit for the development of new drugs, since compounds containing this unit present a broad spectrum of biological activities such as antibacterial, antifungal, analgesic, anti- inflammatory, antiviral, antitumor, antihypertensive, anticonvulsant, etc. We describe the synthesis, characterization and antimicrobial activity of heterocyclic compounds of class 2,3-dihydro- 1,3,4-oxadiazole, specifically, 3-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole, that were obtained as racemic mixture from the reaction of cyclization of N-acylhydrazones using acetic anhydride. Compounds were divided into three sets congeners as follows: series 1 (2-aryl-3- acetyl-5-(pyridin-4-yl)-2,3-dihydro-1,3,4-oxadiazol), series 2 (2-(5-nitrofuran-2-yl)-3-acetyl- 5-aryl-2,3-dihydro-1,3,4-oxadiazol) and series 3 (2-(4-acetoxyphenyl)-3-acetyl-5- aryl-2,3- dihydro-1,3,4-oxadiazol). All compounds were characterized by spectroscopic techniques IR, 1H-NMR, 13C-NMR and mass spectrometry. In the evaluation of the in vitro antimicrobial activity, compounds of the series 2 exhibit efficient activity against several strains of Staphylococcus aureus with minimum inhibitory concentration in the range of 8 to 32μg/mL, being more potent than the standard drug chloramphenicol, and good antifungal activity against six Candida strains with minimum inhibitory concentration values ranging from 64 to 512 μg/mL. / Entre os compostos heterocíclicos, 1,3,4-oxadiazol representa uma importante unidade de construção para o desenvolvimento de novos fármacos, uma vez que compostos que contém esta unidade possuem um amplo espectro de atividades biológicas tais como: antibacteriana, antifúngica, analgésica, anti-inflamatória, antiviral, antitumoral, antihipertensiva, anticonvulsivante, etc. Neste trabalho, descreve-se a síntese, caracterização e atividade antimicrobiana de compostos heterocíclicos da classe 2,3-diidro-1,3,4-oxadiazol, especificamente, 3-acetil-2,5-diaril-2,3-diidro-1,3,4-oxadiazol, que foram obtidos como mistura racêmica a partir da reação de ciclização de N-acilhidrazonas usando anidrido acético. Os compostos foram divididos em três séries congêneres como: série 1 (2-aril-3-acetil-5- (piridin-4-il)-2,3-diidro-1,3,4-oxadiazol), série 2 (2-(5-nitrofuranil)-3-acetil-5-aril-2,3-diidro- 1,3,4-oxadiazol) e série 3 (2-(4-acetoxifenil)-3-acetil-5-aril-2,3-diidro-1,3,4-oxadiazol). Todos os novos compostos foram devidamente caracterizados por técnicas espectroscópicas de IV, RMN de 1H e 13C e espectrometria de massa. Na avaliação da atividade antimicrobiana in vitro, os compostos da série 2 exibiram eficiente atividade frente a diversas linhagens de Staphylococcus aureus ensaiadas com concentração inibitória mínima na faixa de 8-32μg/mL, sendo mais potente do que o fármaco padrão cloranfenicol, e boa atividade antifúngica contra seis linhagens de Candida com concentração inibitória mínima na faixa de 64 a 512μg/mL.

Page generated in 0.0538 seconds